Financial News

NORTH BERGEN, N.J. — The Vitamin Shoppe will buy a Pacific Northwest-based supplement chain, the New Jersey-based company said.

The Vitamin Shoppe said it would buy Super Supplements for $50 million. Super Supplements operates 31 stores in Washington, Oregon and Idaho, and the Vitamin Shoppe said the acquisition would expand its presence in the Northwest, where it already operates 17 stores. The transaction is expected to close on Dec. 31.

OSAKA, Japan — Japanese drug maker Takeda Pharmaceutical is selling its generics business to India-based Sun Pharmaceutical Industries, Takeda said Monday.

Takeda said it would sell URL Pharma, through U.S. subsidiary Takeda Pharmaceuticals USA, to Sun subsidiary Caraco Pharmaceutical Labs while retaining control of the gout treatment Colcrys (colchicine). Takeda acquired rights to Colcrys when it bought URL Pharma for $800 million in June 2012; financial terms of the current deal with Caraco were not disclosed.

ISSAQUAH, Wash. — Growth in sales and membership income at Costco helped the company produce earnings per share of 95 cents and beat analysts’ estimates by 2 cents.

NEW YORK — Kroger and Walmart may be looking to buy up assets from bankrupt food company Hostess Brands, according to published reports.

SEATTLE — A former executive of Car Toys has been appointed CFO of Bartell Drugs, the Seattle-based retail pharmacy chain said.

Rob Jensen has been appointed CFO of Bartell, where he will provide financial analysis and support for the 58-store chain, including supervisory oversight of accounting and finance, information technology, loss prevention and Health Insurance Portability and Accountability Act operations.

CHICAGO — Holiday shoppers continued their quest for the perfect gifts during the week ended Dec. 8, according to ShopperTrak. Consumer activity drove a 7.8% increase in foot traffic and 6.5% increase in sales from the previous week.

WASHINGTON — According to the National Retail Federation, eager holiday shoppers helped November retail sales — excluding automobiles, gas stations and restaurants — increase 0.8% seasonally adjusted from October and increase 4.4% unadjusted year-over-year. The NRF also expects holiday sales to grow 4.1% over the last holiday season.

JERUSALEM — Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, not including royalties, the companies said.